Register
Forgot your password?

Cardiac computed tomography – a promising method for detecting cardiovascular toxicity of antitumor therapy

Authors: Khabarova N.V.1, Ilgisonis I.S.1, Kirichenko Yu.Yu.1, Gagarina N.V.2, Belenkov Yu.N.1

Company: 1 Department of Hospital Therapy No. 1, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
2 Radiology Department, University Clinical Hospital No. 1, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation

For correspondence:  Sign in or register.

Type:  Case reports


DOI: https://doi.org/10.24022/1997-3187-2024-18S-S139-S147

For citation: Khabarova N.V., Ilgisonis I.S., Kirichenko Yu.Yu., Gagarina N.V., Belenkov Yu.N. Cardiac computed tomo- graphy – a promising method for detecting cardiovascular toxicity of antitumor therapy Creative Cardiology. 2024; 18 (Special Issue): S139–S147 (in Russ.). DOI: 10.24022/1997-3187-2024-18S-S139-S147

Keywords: cardiooncology cardiovascular imaging cardiovasculotoxicity computed tomography

Download
Full text:  

 

Abstract

The development of oncological care and the introduction of new treatment methods have led to an increase in the life expectancy of cancer patients, and the problem of early detection of cardiovasculotoxicity of chemotherapy and radiotherapy, the main component of which is timely and highly informative imaging of the cardiovascular system, has come to the forefront. In the clinical recommendations of the European Society of Cardiology on cardiooncology, released in 2022, the basis is ultrasound methods: transthoracic and 3-dimensional echocardiography, as well as global longitudinal strain of the left ventricle. In case of impossibility of ultrasound examination, magnetic resonance imaging is recommended. However, all these methods are less informative for diagnosing of the coronary artery disease, valvular heart disease and pericardial complications, especially in cases of calcification of these structures. In this regard, attention is drawn to the cardiac computed tomography (CT), which allows you to obtain all the information. Our article is devoted to the analysis of the first experience of using the CT method in examining patients with various types of cancer undergoing radiation and chemotherapy.

References

  1. Key facts Cardiovascular Diseases (CVDs), 2017. WHO, World Health Organization. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases. (Accessed March 18, 2019)
  2. Murphy S.L., Kochanek K.D., Xu J., Arias E. Mortality in the United States, 2020. NCHS Data Brief. 2021; (427): 1-8. PMID: 34978528
  3. Wang F.M., Reiter‐Brennan C., Dardari Z., Marshall C.H., Nasir K., Miedema M.D., et al. Association between coronary artery calcium and cardiovascular disease as a supporting cause in cancer: The CAC consortium. Am. J. Prev. Cardiol. 2020; 12 (4): 100119. DOI: 10.1016/j.ajpc.2020.100119
  4. Mladosievicova B., Petrikova L., Valaskova Z., Bernadic M.Jr., Chovanec M., Mego M., Bernadic M. Atherosclerosis in cancer patients. Bratisl. Lek. Listy. 2019; 120 (9): 636–40. DOI: 10.4149/BLL_2019_105
  5. Florido R., Daya N.R., Ndumele C.E., Koton S., Russell S.D., Prizment A., et al. Cardiovascular disease risk among cancer survivors: the Atherosclerosis Risk In Communities (ARIC) Study. J. Am. Coll. Cardiol. 2022; 80 (1): 22–32. DOI: 10.1016/j.jacc.2022.04.042
  6. Polonsky T.S., McClelland R.L., Jorgensen N.W., Bild D.E., Burke G.L., Guerci A.D., Greenland P. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010; 303 (16): 1610–1616. DOI: 10.1001/jama.2010.461
  7. Lyon A.R., López-Fernández T., Couch L.S., Asteggiano R., Aznar M.C., Bergler-Klein J. et al. 2022 ESC Guidelines on cardio‐oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio‐Oncology Society (IC‐OS): Developed by the task force on cardio‐oncology of the European Society of Cardiology (ESC). Eur. Heart J. 2022; 43 (41): 4229–4361. DOI: 10.1093/eurheartj/ehac244
  8. Nasir K., Clouse M. Role of non‐enhanced multidetector CT coronary artery calcium testing in asymptomatic and symptomatic individuals. Radiology. 2012; 264 (3): 637–649. DOI: 10.1148/radiol.12110810
  9. Yeboah J., McClelland R.L., Polonsky T.S., Burke G.L., Sibley C.T., O’Leary D., et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate‐risk individuals. JAMA. 2012; 308 (8): 788–95. DOI: 10.1001/jama.2012.9624
  10. Karady J., Ferencik M. Coronary artery calcium for cardiovascular risk estimation in patients with cancer. Circ. Cardiovasc. Imaging. 2023; 16 (2): e015172. DOI: 10.1161/CIRCIMAGING.123.015172.
  11. Divakaran S., Lopez D.M., Parks S.M., Hainer J., Ng A.K., Blankstein R., et al. Functional testing, coronary artery calcifications, and outcomes in Hodgkin lymphoma survivors treated with chest radiation. Cardio-Oncology. 2023; 9: 5. DOI: 10.1186/s40959-023-00157-2.
  12. Patel S., Franco F.X., McDonald M., Rivera C., Perez‐Villa B., Collier P., et al. Use of computed tomography coronary calcium score for prediction of cardiovascular events in cancer patients: a retrospective cohort analysis. Cardio-Oncology. 2024; 10: 1. DOI: 10.1186/s40959-023-00196-9
  13. Muratov R., Babenko S., Sachkov A., Soboleva N., Andrianova E. Post radiotherapy lesions of the heart valves. Principles of diagnosis and results of treatment. Kardiologiia. 2019; 59 (3): 36–42. DOI: 10.18087/cardio.2019.3.10239
  14. Muratov R., Sorkomov M., Babenko S., Serov R., Zharikova A., Terekhov M. Early postoperative results of cardiac surgery in patients with previous radiotherapy for Hodgkin’s lymphoma. Russian Journal of Cardiology and Cardiovascular Surgery. 2022; 15 (1): 32–39. DOI: 10.17116/kardio20221501132
  15. Becker М., Arruda G., Berenguer D., Buril R., Cardinale D., Brandão S. Anthracycline cardiotoxicity: current methods of diagnosis and possible role of F-FDG PET/CT as a new biomarker. Cardio-Oncology. 2023; 9: 17. DOI: 10.1186/s40959-023-00161-6
  16. Omidi A., Weiss E., Trankle C.R., Rosu‐Bubulac M., Wilson J.S. Quantitative assessment of radiotherapy-induced myocardial damage using MRI: a systematic review. Cardio-Oncology. 2023; 9: 24 DOI: 10.1186/s40959-023-00175-0
  17. Tong J., Vogiatzakis N., Andres M.S., Senechal I., Badr A., Ramalingam S. et al. Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditis. Cardio-oncology. 2024; 10 (1): 53. DOI: 10.1186/s40959-024-00250-0

About Authors

  • Natalia V. Khabarova, Cand. Med. Sci., Assistant; ORCID
  • Irina S. Ilgisonis, Cand. Med. Sci., Professor, ORCID
  • Yulia Yu. Kirichenko, Cand. Med. Sci., Associate Professor; ORCID
  • Nina V. Gagarina, Cand. Med. Sci., Radiologist; ORCID
  • Yuriy N. Belenkov, Academician of the Russian Academy of Sciences, Dr. Med. Sci., Professor, Head of Chair of Hospital Therapy №1; ORCID

Chief Editor

Elena Z. Golukhova, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, Director of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by